transcriptomics

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.

Genetic, transcriptomic, and epigenetic data reveal molecular mechanisms tying these disorders to each other and to immune disfunction.

Genes associated with preterm birth and protecting the fetus from the mother’s immune system appear to be regulated by HAND2.

The presence of a particular set of RNAs in the blood forewarns of an onset of severe symptoms and points to the cells involved.

Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.

A single-cell map of C. elegans’s transcriptome during development finds cell lineages that start out genetically different and end up as cells of similar function and genetic profile.

Researchers track which genes are active in the polyp during successive cell states.

A mollusk grows magnetic teeth so tough they can grind down rocks.  

Researchers identify a new species of Hemimastigophora protist, and suggest the group should be promoted from a phylum to a supra-kingdom.

Rosehip neurons are not found in rodents. Perhaps they offer clues about what separates our brains from those of other animals.

A study suggests that there is more to the eukaryotic genome than was previously suspected.

From single-cell analysis to whole-genome sequencing, this year's best new products shine on many levels.

Adding RNA sequencing analysis to genomic sequencing helps scientists uncover mutations likely responsible for genetic disorders they might otherwise miss.